Food
INVESTORS
home > INVESTORS > Financial Information drop
IR Contact

Financial Information

We introduce ADBIOTECH’s technology intended to replace vaccines and antibiotics.

Sales

Operating profit

Net profit

Income Statements(Unit: KRW in thousands)

Item 2019 2020 2021
Sales 9,343,575 9,815,308 11,840,173
Cost Of Sales 4,858,235 4,405,101 5,012,794
Operating profit 102,140 -996,203 -1,554,598
Non-operating income 298,735 216,651 192,479
Non-operating expense 2,219,731 6,696,842 1,052,577
Net profit -1,705,828 -7,344,923 -2,664,465

Total Assets

Total liabilities

Total equity

Financial Position(Unit: KRW in thousands)

Item 2019 2020 2021
Current Assets 5,856,573 7,249,143 8,672,355
Non-current Assets 6,058,957 11,590,911 12,286,989
Total Assets 11,915,531 18,840,054 20,959,344
Current liabilities 12,748,080 5,494,861 12,625,914
Non-Current liabilities 70,138 4,017,721 3,227,821
Total liabilities 12,818,217 9,512,582 15,853,735
Share capital 822,893 1,267,337 3,846,522
Capital surplus 2,972,978 20,582,470 18,292,579
Retained earnings -6,335,658 -13,605,996 -16,270,462
Total equity -902,687 9,327,472 5,105,608